Abnormal glucose metabolism (AGM) is common but underestimated in patients with coronary heart disease (CHD). Here, we reported 898 in-hospital patients with primary hypertension (PH) at the university hospitals in developed regions of China. Oral glucose tolerance test (OGTT) was performed in those without known type-2 diabetes mellitus (2-DM). A total of 158 patients had known 2-DM and 32 were newly diagnosed as 2-DM by fasting blood glucose (FBG). OGTT revealed that 83 had 2-DM and 296 had impaired glucose tolerance (IGT). The proportion of 2-DM and AGM increased from 21.2 to 30.4% and from 57.5 to 68.7% upon OGTT. Prevalence of AGM and 2-DM increased with the increase of age, and incidence of AGM and 2-DM was significant higher in patients with risk factors (including CHD, overweight, hyperlipidaemia, proteinuria) than those without risk factors mentioned above. Glucose was not sufficiently controlled in 55.1% of the patients with 2-DM upon treatment, well controlled in 35.4% and not controlled in 9.5%. So AGM is also prevalent in PH patients especially the elders and those with risk factors, which was underestimated in most cases. Moreover, much lower awareness, treatment and control of 2-DM occurred in some regions of China, thus strengthening health education for patients and heightening consciousness of doctor are very important and eminent. Except for FBG, more attention should be paid to postprandial blood glucose ignored before, and OGTT should be a routine procedure in PH patients, especially in older patients and those with the factors mentioned above.
Introduction
Type-2 diabetes mellitus (2-DM) and other glucometabolic abnormities, which are increasing rapidly nowadays, have become major risk factors for cardiocerebrovascular events, [1] [2] [3] [4] while primary hypertension (PH) is another risk factor for cardiocerebrovascular events. 5, 6 Framingham Heart Study, Treatment of Mild Hypertension Study and Multiple Risk Factor Intervention Trial Study all showed that higher blood pressure, including systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure, was an independent risk factor of coronary heart disease (CHD). [7] [8] [9] [10] UK Prospective Diabetes Study and Hypertension in Diabetes Study showed that tight blood pressure control in 2-DM patients could significantly reduce the risks of virtually all cardiovascular and microvascular outcomes. 11, 12 In fact, many PH patients also suffer from 2-DM, and people with 2-DM have twice the annual mortality rate of non-2-DM individuals, which is mainly owning to cardiovascular disease. 13 So it is very important for PH patients to evaluate their glucometabolic state. At clinics, doctors pay more attention to the fasting blood glucose (FBG) level in PH or CHD patients, but ignore the postprandial blood glucose level. There were studies from Nigeria, Spain and Brazil that showed that impaired glucose tolerance (IGT) and some kinds of abnormal glucose metabolism (AGM) were also prevalent in PH patients. [14] [15] [16] But little evidence was given to indicate the glucometabolic state of PH patients in China. This study was performed about the awareness and control status of AGM, and mainly about the incidence of undiagnosed 2-DM and IGT in patients with PH to assess the prevalence of AGM in China, and to provide more evidence to improve the consciousness in PH patient management strategies.
Methods

Patients and data collection
The study complies with the Declaration of Helsinki. The data collection protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Sun Yat-sen University and Taizhou Hospital affiliated to Wenzhou Medical College. All the participants consented to use their data by anonymous means.
A total of 898 participants enrolled into this study came from the in-hospital PH patients in cardiovascular department of the Second Affiliated Hospital of Sun Yat-sen University and Taizhou Hospital affiliated to Wenzhou Medical College. Data were collected and recorded in special form for this study by serial number but not by patients' name or record number. Individuals over 80 years old or with secondary hypertension, type-1 diabetes, obvious hypohepatia, autoimmune diseases (including thyroid diseases and some diseases treated with hormone) or some severe worse controlled infective diseases were excluded from the study.
Diagnosis of hypertension, CHD and proteinuria
Hypertension was defined according to criterion of the Chinese Hypertension League: SBPX140 mm Hg and/or DBPX90 mm Hg or current antihypertensive treatment. Ultrasonography of kidney, adrenal glands and renal artery was the routine examinations for every PH patient. Related hormonals (for example plasma aldosterone, catecholamine, cortisol, angiotensin, urinary vanillylmandelic acid and so on) and factors of secondary hypertension were examined, in those with refractory hypertension or with age younger than 40, to exclude secondary hypertension. CHD was diagnosed by coronary angiography (CAG) or 64-slice CT angiography (CTA) of coronary artery. Those not accepting CAG or CTA, CHD was diagnosed by typical complain of angina combined with at least one typical objective finding including ischaemic changes in electrocardiogram or nuclear myocardial perfusion imaging, regional wall motion abnormalities in echocardiogram or positive treadmill exercise test. CHD was defined by angiography that 450% stenosis of the lumen diameter occurred in one or more major coronary arteries. Those with history of known myocardial infarction or revascularization treatment (including percutaneous coronary intervention or coronary artery bypass grafting) were also ascertained as CHD. Microalbuminuria was defined by urine album eliminate rate of 24 h urine (420 mg min À1 ) and proteinuria was defined by the protein of 24 h urine (4150 mg).
Measurement of lipometabolic and glucometabolic state Hyperlipidaemia was defined, by Chinese Cholesterol Education Program and Chinese Guideline of Prevention and Treatment of Dyslipidemia in adult, 17 as follows: total cholesterol X5.18 mmol l
À1
(200 mg per 100 ml), and/or high-density lipoprotein cholesterolp1.04 mmol l
(40 mg per 100 ml) and/or low-density lipoprotein cholesterolX3.37 mmol l À1 (140 mg per 100 ml) and/or triglyceridesX1.70 mmol l À1 (150 mg per 100 ml) or undergoing current lipid-lowering treatment.
New cut point (5.6 mmol l À1 ) of impaired fasting glucose (IFG) suggested by American Diabetes Association 18 was adopted in this study. Patients with previously known 2-DM did not undergo oral glucose tolerance test (OGTT, 75 g anhydrous glucose in 200-300 ml water). Plasma glucose levels were measured by hexokinase method at the start of the OGTT (0 min) and at 2 h postprandial (2 h). 432w>Those with newly diagnosed 2-DM (FBGX7.0 mmol l À1 butp11.1 mmol l À1 in two consecutive tests), IFG patients (FBGX5.6 but o7.0 mmol l) À1 and the left patients underwent OGTT to evaluate their glucometabolic state. We tested bedside blood glucose from fingertip every 30 min in every new diagnosed 2-DM patient (by two consecutive FBG) to avoid exceedingly high blood glucose or severe adverse events. HbA1c was measured in every patient. OGTT was performed in those with acute illness after they recovered from illness to avoid the influence of acute illness on glucose tolerance. Usually, it was performed before patients left hospital. Except for those having to accept treatment with b-blocker or diuretics (for example, patients with CHD, heart failure or dissection of aorta), b-blocker or diuretics were not used for patients until the OGTT was finished. AGM includes IFG, IGT and 2-DM.
Statistics
All the data colleted were analysed using SPSS statistical software 12.0. Difference in continuous variables between groups was analysed with analysis of variance test. The comparison of percentage between groups was analysed with w 2 -test.
Results
Patient data of demographics and clinical characteristics A total of 898 in-hospital PH patients were enrolled into the study, with demographics and clinical characteristics listed in Table 1 . Of them, 54.2% of the patients enrolled were male. Average age was 60 years and female patients' average age was older than the male patients' (Po0.01). Body mass index (BMI) and percentage of smoking in male patients were significant higher than that in female. Total prevalence of CHD in male patients was significant higher than that in female (Po0.01), but there was no significant difference between male and female patients over 65 years old (P40.05). There was no significant difference between female and male patients in incidence of hyperlipidaemia, atrial fibrillation, family history of hypertension and diabetes, proteinuria (or microalbuminuria) and heart failure (P40.05). (Figure 1 ). Prevalence of AGM and 2-DM increased Abbreviations: BMI, body mass index; CHD, coronary heart disease; DM, diabetes mellitus. Data are median (lower-upper quartiles) and number of patients (%).
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Left participants with the increase of age, and incidence of AGM and 2-DM was significantly higher in patients with risk factors (including CHD, overweight, hyperlipidaemia, proteinuria) than those without risk factors mentioned above (Tables 2 and 3) . Most patients (55.1%, 87 of 158) with previously known 2-DM have received anti-diabetes therapy (including drugs and/or insulin) but were poorly controlled (HbA1cX6.5%). Some (35.4%, 56 of 158) have received normative therapy and were better controlled (HbA1co6.5%), and a few patients (9.5%, 15 of 158) dropped off from anti-diabetes therapy or even had never received any antidiabetes therapy (HbA1cX6.5%). HbA1c was over 6.5% in 81.4% (92 of 113) newly diagnosed 2-DM patients and 9.6% (27 of 282) in newly diagnosed IGT patients (excluding 6 new 2-DM patients diagnosed by FBG).
Discussion
The prevalences of DM and IGT in the Western Pacific region in 2003 were about 3.1 and 5.7%, 19 and 5.67 and 5.77% respectively in middle-aged and old people of China. 20 Both Euro Heart Survey and China Heart Survey demonstrated that DM and IGT were prevalent in CHD. 21, 22 Most of the present studies concerned the state of controlling hypertension of DM, but only a few studies focused on the state of glucose metabolism of PH patients. This study showed that the prevalence of 2-DM, IGT and AGM were 30.4, 32.3 and 68.7% respectively in inhospital PH patients. But if they had not accepted OGTT, 9.2 and 11.2% of these PH patients would be undiagnosed 2-DM and AGM, which means many patients would lose the chance to treat glucose metabolism disorder earlier to reduce the possible risk of target organ damage. In the past years, more attention was paid to FBG, but few to postprandial blood glucose. In fact, some studies [14] [15] [16] and our study showed some patients with normal FBG also suffered from IGT or even 2-DM. So it is urgent that OGTT should be performed more prevailing or even as the routine test for PH patients especially for those with risk factors mentioned above.
This study also showed that most known 2-DM patients with PH (54.4%) controlled blood glucose worse, though they accepted the medical treatment, and even some had never accepted any anti-diabetes therapy or had not insisted on anti-diabetes therapy, only about one-third known 2-DM patients have their blood glucose well controlled, and many patients even did not know they had already suffered from 2-DM or IGT. Similar results were demonstrated in another study about common DM patients. 23 These let us realize that it is very urgent to strengthen sustainable health education in patients, besides, screening AGM by OGTT and strengthening long-term follow-up for AGM patients should prevail in doctors, which helps to decrease . the probability of future complication as much as possible. Nonetheless, the study has several limitations that weaken its main conclusion. First, this is not a population-based study, and is not a multi-centre but double-centre study. This may limit the extrapolation of the study results to the patients of other regions or hospitals. Even so, because this study was finished in two of the biggest hospitals of Zhejiang and Guangdong, two most developed provinces in China, the data were supposed to reflect the main status of the other hospital or region. So high prevalence of AGM, low awareness and control rate of 2-DM were in this two provinces, let alone that in most underdeveloped provinces or some common hospitals.
In summary, AGM is common and undiagnosed in most patients admitted into hospital with PH regardless of man or woman, with or without symptoms or risk factors. Regardless of whether these PH patients have risk factors mentioned above, we should investigate their glucometabolic state. For AGM can result in cardiovascular events and some other target organ damage, the earlier we find it and control it, the less complication patients will undergo. As OGTT plays a key role in recognizing AGM and it is cheaper and convenient, so it should be added as the routine examination in the patients with PH or other cardiovascular diseases. The more concomitant risk factors the patient has, the more attention doctor should pay to their glucometabolic state. What is known about the topic K Glucometabolic abnormality is common in patients with coronary heart disease (CHD), vice versa, CHD is common in patients with glucometabolic abnormality. K Few studies reveal glucometabolic state in patients with primary hypertension (PH) especially in China. K The status of awareness rate, treatment rate and control rate of 2-DM population with PH in cardiovascular department, especially in developed region or university hospitals of China, is unclear.
What this study adds K This study demonstrates that abnormal glucose metabolism (AGM) is prevalent in in-hospital PH patients especially in patients with risk factors, and AGM increases with the increase of age in China. K AGM is frequent even in some patients with normal FBG, so just like FBG, more attention should be paid to postprandial blood glucose. K Our findings further support that OGTT is very important to find new AGM and should be performed routinely not only in CHD patients, but also in PH patients. Health education should be strengthened for patients.
Abbreviations: FBG, fasting blood glucose; OGTT, oral glucose tolerance test.
